Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
出版年份 2019 全文链接
标题
Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
作者
关键词
-
出版物
MYCOSES
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-06-29
DOI
10.1111/myc.12960
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
- (2019) Lauren Fontana et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data
- (2018) Elizabeth A. Lakota et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata
- (2018) Justin C. Bader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
- (2018) David Ghez et al. BLOOD
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Overview of selected virulence attributes in Aspergillus fumigatus , Candida albicans , Cryptococcus neoformans , Trichophyton rubrum , and Exophiala dermatitidis
- (2018) Hazal Boral et al. FUNGAL GENETICS AND BIOLOGY
- Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples
- (2018) Sven Heldt et al. JOURNAL OF INFECTION
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
- (2018) Felix C. Koehler et al. Frontiers in Microbiology
- Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium , San Diego: The Role of Antifungal Combination Therapy
- (2018) Jeffrey D. Jenks et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together
- (2018) Martin Hoenigl et al. MYCOSES
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units.Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project
- (2018) M. Bassetti et al. MYCOSES
- Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus -specific Lateral Flow Device test in bronchoalveolar lavage
- (2018) Jeffrey D. Jenks et al. MYCOSES
- Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis
- (2017) J. J. Vehreschild et al. EUROPEAN RADIOLOGY
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
- (2017) Romuald Bellmann et al. INFECTION
- Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
- (2017) Ray Hachem et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations
- (2017) Katharine E. Stott et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
- (2017) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers
- (2017) P. Lewis White et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The global problem of antifungal resistance: prevalence, mechanisms, and management
- (2017) David S Perlin et al. LANCET INFECTIOUS DISEASES
- Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study
- (2017) Giovanni L Breda et al. MEDICAL MYCOLOGY
- Pseudomonas phage inhibition of Candida albicans
- (2017) Hasan Nazik et al. MICROBIOLOGY-SGM
- Improving outcome of fungal diseases - Guiding experts and patients towards excellence
- (2017) Oliver A. Cornely et al. MYCOSES
- Candida -reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spine
- (2017) Felix C. Koehler et al. MYCOSES
- Pseudozymaand other non-Candidaopportunistic yeast bloodstream infections in a large stem cell transplant center
- (2017) Anupam Pande et al. Transplant Infectious Disease
- Biofilm Formation by Pseudallescheria/Scedosporium Species: A Comparative Study
- (2017) Rodrigo Rollin-Pinheiro et al. Frontiers in Microbiology
- Phase 1 Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001 and to Investigate the Effect of Food on APX001 Bioavailability
- (2017) Michael R Hodges et al. Open Forum Infectious Diseases
- Pharmacokinetics 101
- (2017) Shinya Ito Paediatrics & Child Health
- Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)
- (2016) Laura L. Kovanda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels
- (2016) Jürgen Prattes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Problematic Dichotomization of Risk for Intensive Care Unit (ICU)–Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients
- (2016) E. Geoffrey Playford et al. CLINICAL INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Breakthrough candidaemia in the era of broad-spectrum antifungal therapies
- (2016) G. Cuervo et al. CLINICAL MICROBIOLOGY AND INFECTION
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure
- (2016) Jean-Francois Timsit et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
- (2016) Lena M. Biehl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection
- (2016) Francesco Barchiesi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary
- (2016) Shahid Husain et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis
- (2016) Jesús Fortún et al. LIVER TRANSPLANTATION
- Pf4 bacteriophage produced by Pseudomonas aeruginosa inhibits Aspergillus fumigatus metabolism via iron sequestration
- (2016) Jack C. Penner et al. MICROBIOLOGY-SGM
- Surgical Site Infections After Liver Transplantation
- (2016) J. Alexander Viehman et al. TRANSPLANTATION
- Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence
- (2016) Ronen Ben-Ami et al. mBio
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report
- (2016) Fernando Cobo et al. Infectious Diseases
- Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
- (2016) Pascalis Vergidis et al. PLoS One
- Fungus-Specific CD4+T Cells for Rapid Identification of Invasive Pulmonary Mold Infection
- (2015) Petra Bacher et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Combination Antifungal Therapy for Invasive Aspergillosis
- (2015) Kieren A. Marr et al. ANNALS OF INTERNAL MEDICINE
- Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae
- (2015) Anne-Pauline Bellanger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
- (2015) Eleftherios Mylonakis et al. CLINICAL INFECTIOUS DISEASES
- Role of Echinocandins in Fungal Biofilm–Related Disease: Vascular Catheter–Related Infections, Immunomodulation, and Mucosal Surfaces
- (2015) Aspasia Katragkou et al. CLINICAL INFECTIOUS DISEASES
- Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
- (2014) D.J. Winston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
- (2014) Fernando César Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
- (2014) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
- (2014) Faouzi Saliba et al. CLINICAL INFECTIOUS DISEASES
- Invasive fungal infections in solid organ transplant recipients
- (2014) J. Gavaldà et al. CLINICAL MICROBIOLOGY AND INFECTION
- Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
- (2014) N. Lerolle et al. CLINICAL MICROBIOLOGY AND INFECTION
- Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study
- (2014) David Nachbaur et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies
- (2014) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of caspofungin in ICU patients
- (2014) E. W. Muilwijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation
- (2014) A. Wojtowicz et al. JOURNAL OF INFECTIOUS DISEASES
- Our 2014 approach to breakthrough invasive fungal infections
- (2014) Georg Maschmeyer et al. MYCOSES
- Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
- (2014) Cristina Cunha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empirical Fluconazole versus Placebo for Intensive Care Unit Patients
- (2013) Mindy G. Schuster ANNALS OF INTERNAL MEDICINE
- Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
- (2013) Martin Hoenigl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
- (2013) Faouzi Saliba et al. CLINICAL TRANSPLANTATION
- Pathogenesis of invasive fungal infections
- (2013) Carolina Garcia-Vidal et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
- (2013) C Orla Morrissey et al. LANCET INFECTIOUS DISEASES
- Preemptive treatment with voriconazole in lung transplant recipients
- (2013) C.F. Neoh et al. Transplant Infectious Disease
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
- (2012) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study
- (2012) J. Auberger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics of Voriconazole in Adults
- (2011) William W. Hope ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
- (2011) A. Bergeron et al. BLOOD
- Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
- (2011) David I. Marks et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune reconstitution syndrome and fungal infections
- (2011) Ashish O. Gupta et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Aspergillus biofilms: clinical and industrial significance
- (2011) Gordon Ramage et al. FEMS MICROBIOLOGY LETTERS
- The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project
- (2011) L. Pagano et al. HAEMATOLOGICA
- Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
- (2011) M. R. Ananda-Rajah et al. HAEMATOLOGICA
- Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
- (2011) Ban Hock Tan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients
- (2011) Shahid Husain et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Breakthrough invasive mould infections in patients treated with caspofungin
- (2011) Katy-Anna Phai Pang et al. JOURNAL OF INFECTION
- Aspergillus fumigatusbiofilms in the clinical setting
- (2011) Frank-Michael C. Müller et al. MEDICAL MYCOLOGY
- Italian Guidelines for Diagnosis, Prevention, and Treatment of Invasive Fungal Infections in Solid Organ Transplant Recipients
- (2011) P.A. Grossi et al. TRANSPLANTATION PROCEEDINGS
- Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
- (2010) J. R. Wingard et al. BLOOD
- Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
- (2010) Marya D Zilberberg et al. BMC INFECTIOUS DISEASES
- Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
- (2010) O Blennow et al. BONE MARROW TRANSPLANTATION
- Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
- (2010) J. J. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ICU-acquired immunosuppression and the risk for secondary fungal infections
- (2010) Guillaume Monneret et al. MEDICAL MYCOLOGY
- Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study
- (2010) M. Winkler et al. Transplant Infectious Disease
- Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
- (2009) J. Cadena et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
- (2009) Catherine Cordonnier et al. CLINICAL INFECTIOUS DISEASES
- Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
- (2009) Cristóbal León et al. CRITICAL CARE MEDICINE
- Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study
- (2009) Corrado Girmenia et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Virulence of Zygomycetes Organisms Following Exposure to Voriconazole: A Study Involving Fly and Murine Models of Zygomycosis
- (2009) Gregory A. Lamaris et al. JOURNAL OF INFECTIOUS DISEASES
- Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit
- (2009) Luis Ostrosky-Zeichner et al. MYCOSES
- The sepsis seesaw: tilting toward immunosuppression
- (2009) Richard S Hotchkiss et al. NATURE MEDICINE
- A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
- (2008) H Hebart et al. BONE MARROW TRANSPLANTATION
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation
- (2008) Jan Groetzner et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation
- (2008) Pierre-Yves Bochud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis
- (2008) Aimee K. Zaas et al. PLoS Genetics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started